EUVIMEDOpdag EUVIMED
Open access

A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC

Nishanth Kuganesan iD, Margaret Pan, Haowen Jiang iD, Stavros Melemenidis iD, Jiangbin Ye iD, Sara Richter iD, Maximillian Diehn iD, Kerriann M Casey iD, Edward E Graves iD, Quynh Thu Le iD, Erinn B Rankin iD

Science Advances · 2026

DOI: 10.1126/sciadv.aed6463 ↗

At a glance

Journal article in Science Advances, 2026. Written by Nishanth Kuganesan and 10 co-authors. Institution: Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Cysteine, Amino Acid Transport System y+. Cited 2 times so far (Crossref); 62 references. The full text is freely available in PubMed Central. Funded by: National Institutes of Health, American Cancer Society.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cysteine metabolism plays a crucial role in the growth and survival of non–small cell lung cancer (NSCLC), although the mechanisms governing its regulation are not fully understood. Here, we demonstrate that the RNA demethylase FTO is a therapeutic target that drives cysteine metabolism in NSCLC cells. Genetic or pharmacologic inhibition of FTO reduced cystine uptake and transsulfuration activity, leading to depleted intracellular glutathione, elevated reactive oxygen species (ROS), and ROS-mediated DNA damage and cell death. Mechanistically, FTO promotes the expression of the cystine uptake transporter SLC7A11 and the transsulfuration enzymes cystathionine β-synthase (CBS) and cystathionine γ-lyase (CTH) to promote NSCLC cystine uptake, transsulfuration activity, and survival. FTO inhibition increased lipid peroxidation, reduced tumor growth, and resulted in additive therapeutic benefit in combination with radiotherapy in multiple NSCLC xenograft models. Collectively, our study reveals a role for FTO in cysteine metabolism and highlights the therapeutic potential of targeting cancer epitranscriptomics and cysteine metabolism for NSCLC therapy.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Non-Small-Cell LungAlpha-Ketoglutarate-Dependent Dioxygenase FTOCysteineAmino Acid Transport System y+Lung NeoplasmsCystathionine gamma-LyaseCystathionine beta-SynthaseHumansAnimalsMiceCell Line, TumorReactive Oxygen SpeciesCell ProliferationXenograft Model Antitumor AssaysGene Expression Regulation, Neoplastic

Substances

Alpha-Ketoglutarate-Dependent Dioxygenase FTOCysteineAmino Acid Transport System y+SLC7A11 protein, humanCystathionine gamma-LyaseCystathionine beta-SynthaseReactive Oxygen SpeciesFTO protein, human

Authors and institutions

  • Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA.
  • Department of Comparative Medicine, Stanford University, Stanford, CA 94305, USA.
  • Department of Obstetrics and Gynecology, Stanford University, Stanford, CA 94305, USA.

ORCID profiles: Nishanth Kuganesan, Haowen Jiang, Stavros Melemenidis, Jiangbin Ye, Sara Richter, Maximillian Diehn, Kerriann M Casey, Edward E Graves, Quynh Thu Le, Erinn B Rankin

Funding

  • National Institutes of Health
  • American Cancer Society

Cite

APA

Kuganesan, N., Pan, M., Jiang, H., Melemenidis, S., Ye, J., Richter, S., Diehn, M., Casey, K. M., Graves, E. E., Le, Q. T., & Rankin, E. B. (2026). A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC. Science Advances. https://doi.org/10.1126/sciadv.aed6463

Vancouver

Kuganesan N, Pan M, Jiang H, Melemenidis S, Ye J, Richter S, et al. A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC. Science Advances. 2026. doi:10.1126/sciadv.aed6463

BibTeX
@article{Kuganesan2026,
  author = {Kuganesan, Nishanth and Pan, Margaret and Jiang, Haowen and Melemenidis, Stavros and Ye, Jiangbin and Richter, Sara and Diehn, Maximillian and Casey, Kerriann M and Graves, Edward E and Le, Quynh Thu and Rankin, Erinn B},
  title = {A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aed6463}
}
Start for free →